532742 Stock Overview
Manufactures and sells specialty chemicals and intermediates in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Paushak Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹5,196.55 |
| 52 Week High | ₹6,399.00 |
| 52 Week Low | ₹4,464.00 |
| Beta | 0.68 |
| 11 Month Change | 1.41% |
| 3 Month Change | -17.17% |
| 1 Year Change | -13.66% |
| 33 Year Change | -46.47% |
| 5 Year Change | 110.30% |
| Change since IPO | 1,949.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| 532742 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 2.4% | -0.8% | 0.5% |
| 1Y | -13.7% | 10.7% | 27.5% |
Return vs Industry: 532742 underperformed the Indian Chemicals industry which returned 10.7% over the past year.
Return vs Market: 532742 underperformed the Indian Market which returned 27.5% over the past year.
Price Volatility
| 532742 volatility | |
|---|---|
| 532742 Average Weekly Movement | 3.6% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 532742 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 532742's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 365 | Abhijit Joshi | www.paushak.com |
Paushak Limited manufactures and sells specialty chemicals and intermediates in India and internationally. It offers chloroformates, isocyanates, chlorides, carbonate/carbamate, and others. The company servers its products to pharmaceuticals, agrochemicals, and performance and custom synthesis industries.
Paushak Limited Fundamentals Summary
| 532742 fundamental statistics | |
|---|---|
| Market cap | ₹16.02b |
| Earnings (TTM) | ₹563.93m |
| Revenue (TTM) | ₹2.15b |
28.4x
P/E Ratio7.5x
P/S RatioIs 532742 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 532742 income statement (TTM) | |
|---|---|
| Revenue | ₹2.15b |
| Cost of Revenue | ₹521.88m |
| Gross Profit | ₹1.63b |
| Other Expenses | ₹1.06b |
| Earnings | ₹563.93m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 182.97 |
| Gross Margin | 75.72% |
| Net Profit Margin | 26.23% |
| Debt/Equity Ratio | 0% |
How did 532742 perform over the long term?
See historical performance and comparison